Bill Sponsor
Senate Bill 3174
116th Congress(2019-2020)
Reversing the Youth Tobacco Epidemic Act of 2020
Introduced
Introduced
Introduced in Senate on Jan 9, 2020
Overview
Text
Introduced
Jan 9, 2020
Latest Action
Jan 9, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3174
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Ohio
Democrat
California
Democrat
Delaware
Democrat
Delaware
Democrat
Illinois
Democrat
Maryland
Democrat
Massachusetts
Democrat
New Hampshire
Democrat
Rhode Island
Democrat
Rhode Island
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Reversing the Youth Tobacco Epidemic Act of 2019

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

  • requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
  • requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
  • prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
  • prohibits flavors other than tobacco in a tobacco product;
  • prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
  • increases the user fees that the FDA collects from manufacturers and importers;
  • directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco);
  • establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities;
  • increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
  • requires the Government Accountability Office to study e-cigarettes.  
Text (1)
January 9, 2020
Actions (2)
01/09/2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
01/09/2020
Introduced in Senate
Public Record
Record Updated
Feb 8, 2022 11:22:52 PM